Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Revenue

Rekah Pharmaceutical Industry had revenue of 87.19M ILS in the quarter ending September 30, 2024, with 9.05% growth. This brings the company's revenue in the last twelve months to 331.60M, up 5.17% year-over-year. In the year 2023, Rekah Pharmaceutical Industry had annual revenue of 321.66M with 10.01% growth.

• Revenue (ttm): 331.60M
• Revenue Growth: +5.17%
• P/S Ratio: 0.40
• Revenue / Employee: 776.57K
• Employees: 427
• Market Cap: 135.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	321.66M	29.27M	10.01%
Dec 31, 2022	292.39M	28.44M	10.78%
Dec 31, 2021	263.95M	-1.52M	-0.57%
Dec 31, 2020	265.47M	68.97M	35.10%
Dec 31, 2019	196.50M	-2.07M	-1.04%